Ask AI
ProCE Banner Series

XDROs in Complex Clinical Infections: An Advanced Course on the Hardest-to-Treat Cases

Learn about infections caused by Gram-negative extensively drug-resistant organisms (XDROs) including molecular epidemiology associated with antimicrobial resistance and approaches to selecting treatment regimens based on the latest data, patient-specific factors and pharmacokinetic/pharmacodynamic considerations through challenging clinical cases led by expert faculty.

  ACPE
  | AMA
  | ANCC
Credits Available


Who Should Attend

NPs, PAs and Physicians

All Events

XDROs in Complex Clinical Infections: An Advanced Course on the Hardest-to-Treat Cases

Past Events

February

06

2023

6:30 PM - 7:30 PM Eastern Time (ET)

In-personVirtual

Morton's The Steakhouse North Miami Beach, 17399 Biscayne Blvd, Miami, Florida 33160

Topics

  • About extensively drug-resistant organisms (XDROs)
  • Interactive patient cases of infections caused by:
    • Carbapenem-resistant Acinetobacter baumannii
    • Pseudomonas aeruginosa with difficult-to-treat resistance
    • Metallo-β-lactamase–producing Enterobacterales

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve participants’ competence in selecting appropriate antibiotic regimens for empiric or targeted treatment of complex clinical infections caused by antimicrobial resistant gram-negative pathogens.

Target Audience
This program is intended for physicians (eg, critical care/pulmonologist, infectious disease, internal medicine/hospitalist), pharmacists (critical care, infectious disease), nurses, and other healthcare professionals (eg, NPs/PAs, microbiologists) who provide care for patients with antimicrobial resistant gram-negative infections.

Learning Objectives:
Upon completion of this activity, participants should be able to:

  • Dfferentiate clinically relevant extensively drug resistant gram-negative organisms (XDROs) including epidemiology, mechanisms of antimicrobial resistance, and virulence factors
  • Compare novel antimicrobial treatment options for patients with antimicrobial resistant gram-negative infections including pharmacokinetics/pharmacodynamics and activity in the setting of key resistance mechanisms
  • Apply latest data and suggested approaches for selection of optimized treatment regimens targeting XDROs in patients with complex clinical infections

Accreditation

 

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-22-250-L01-P

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC

Supported by an educational grant from Shionogi Inc.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address:


Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191